Showing results (131-140 of 429) with videos related to
Sort By:
Pageof 43
Arzneimittel-Forschung|May 27, 2006
Bioisosteric modification of salvinorin A, a potent and selective kappa-opioid receptor agonistD Jeremy Stewart, Hesham Fahmy, Bryan L Roth, et al.Journal of Medicinal Chemistry|January 19, 2008
Binding of serotonin and N1-benzenesulfonyltryptamine-related analogs at human 5-HT6 serotonin receptors: receptor modeling studiesMałgorzata Dukat, Philip D Mosier, Renata Kolanos, et al.Pharmacology & Therapeutics|May 28, 2004
Screening the receptorome to discover the molecular targets for plant-derived psychoactive compounds: a novel approach for CNS drug discoveryBryan L Roth, Estela Lopez, Scott Beischel, et al.Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligandBlaine N Armbruster, Xiang Li, Mark H Pausch, et al.American Journal of Physiology. Cell Physiology|June 25, 2010
RNA interference screen for RGS protein specificity at muscarinic and protease-activated receptors reveals bidirectional modulation of signalingGeneviève Laroche, Patrick M Giguère, Bryan L Roth, et al.Cell|December 4, 2024
Structure-guided design of a peripherally restricted chemogenetic systemHye Jin Kang, Brian E Krumm, Adrien Tassou, et al.Nature|February 22, 2018
Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidoneSheng Wang, Tao Che, Anat Levit, et al.Journal of Medicinal Chemistry|January 22, 2005
Studies toward the pharmacophore of salvinorin A, a potent kappa opioid receptor agonistThomas A Munro, Mark A Rizzacasa, Bryan L Roth, et al.The Journal of Biological Chemistry|January 22, 2002
Evidence for a model of agonist-induced activation of 5-hydroxytryptamine 2A serotonin receptors that involves the disruption of a strong ionic interaction between helices 3 and 6David A Shapiro, Kurt Kristiansen, David M Weiner, et al.European Journal of Pharmacology|December 25, 2012
Neurochemical profiles of some novel psychoactive substancesLes Iversen, Simon Gibbons, Ric Treble, et al.Pageof 43